“…This makes it possible to regard the compounds as potential products for the treatment of neurodegenerative illnesses. Such compounds include, for example, 5-(2-hetarylethyl) [28], 5-(2-pyridylvinyl) [37], and 8-sulfonyl [44] derivatives of tetrahydro-γ-carbolines. The drug Dimebon 2 [28,130], which will be discussed in greater detail below, is regarded as an antagonist of serotonin 5-HT 6 -receptors.…”